Oria Bioscience - About the company
Oria Bioscience is an unfunded company based in Paris (France), founded in 2024 by Alexandre Santinho, Marine Moutia and Abdou Rachid Thiam. It operates as a Provider of isolated functional organelles for use in drug discovery. Oria Bioscience has not raised any funding yet. The company has 996 active competitors, including 47 funded and 98 that have exited. Its top competitors include companies like Abcam, Meridian Bioscience and Enzo.
Company Details
Provider of isolated functional organelles for use in drug discovery. The organization utilizes a microfluidic platform to extract and sort intact organelles, including lysosomes and mitochondria. These preparations maintain biological integrity and functional stability, allowing for reproducible data in research workflows. By supplying refined organelle samples, the technology supports investigations into ion channels, cellular assays, and various disease models. Researchers incorporate these systems to improve predictive accuracy in preclinical development and therapeutic screening processes.
Key Metrics
Founded Year
2024
Location
Paris, France
Stage
Unfunded
Ranked
89th among 996 active competitors
Employee Count
21 as on Aug 31, 2026
Sign up to download Oria Bioscience's company profile
Oria Bioscience's funding and investors
Oria Bioscience has not raised any funding rounds yet.
Oria Bioscience's founders and board of directors
Founder? Claim ProfileThe founders of Oria Bioscience are Alexandre Santinho, Marine Moutia and Abdou Rachid Thiam. Alexandre Santinho is the CEO of Oria Bioscience.
Here are the details of Oria Bioscience's key team members:
- Alexandre Santinho: Co-Founder & CEO of Oria Bioscience. Contact Info: 1 email address
- Marine Moutia: Co-Founder & COO of Oria Bioscience. Contact Info: 1 email address
- Abdou Rachid Thiam: Founder of Oria Bioscience of Oria Bioscience.
View details of Oria Bioscience's Founder profiles and Board Members
Oria Bioscience's employee count trend
Oria Bioscience has 21 employees as of Aug 26. Here is Oria Bioscience's employee count trend over the years:
Uncover Oria Bioscience's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Oria Bioscience's Competitors and alternates
Top competitors of Oria Bioscience include Abcam, Meridian Bioscience and Enzo. Here is the list of Top 10 competitors of Oria Bioscience, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Abcam 1998, Cambridge (United Kingdom), Acquired | Developer of biological reagents for life science research | $78.8M | 76/100 | |
2nd | Meridian Bioscience 1976, Ohio (United States), Acquired | Molecular diagnostic device and kits | - | 65/100 | |
3rd | Enzo 1976, Farmingdale (United States), Acquired | Life science products and services for research, drug discovery, and manufacturing | $7M | 65/100 | |
4th |  Huwel Life 2015, Hyderabad (India), Series A | Molecular diagnostic solutions and products for the healthcare industry | $5.74M | 59/100 | |
5th | Stem Cell Technologies 1993, Vancouver (Canada), Series A | Developer of cell culture media and ancillary reagents for life science research | $11.9M | 58/100 | |
6th | Cell culture reagents for stem cell research | $18.2M | 56/100 | ||
7th | Teknova 1996, Hollister (United States), Public | Provider of molecular biology research reagents and kits | - | 56/100 | |
8th | PL BioScience 2015, Aachen (Germany), Series A | Manufacturer of human platelet lysate products for cell culture applications | $13M | 55/100 | |
9th | Luminex 1995, Austin (United States), Acquired | Developer of instruments, reagents and kits for clinical diagnostics and life science research | - | 55/100 | |
10th | Firefly BioWorks 2009, Cambridge (United States), Acquired | Develops platform to allow multiplexed assays on standard laboratory instrumentation | $3.77M | 54/100 | |
89th | Oria Bioscience 2024, Paris (France), Unfunded | Provider of isolated functional organelles for use in drug discovery | - | - | 34/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Oria Bioscience's competitors? Click here to see the top ones
Oria Bioscience's Investments and acquisitions
Oria Bioscience has made no investments or acquisitions yet.
Reports related to Oria Bioscience
Here is the latest report on Oria Bioscience's sector:
Are you a Founder ?
FAQs about Oria Bioscience
Explore our recently published companies
- Integrated Power Products - Point Clear based, Unfunded company
- NexGlobo - Kaunas based, 2025 founded, Unfunded company
- Spotty Elephant CRM and Roleplays - Daventry based, 2025 founded, Unfunded company
- Rex Yiannis - Oceanside based, 2025 founded, Unfunded company
- Morse Code Fund - Las Vegas based, 2025 founded, Unfunded company
- Anchor AI - Unfunded company
